Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Acta Cytologica 2011;55:481–484

Key Cytological Findings in FNA from Infantile Digital Fibromatosis

Ojha S.S. · Naik L.P. · Fernandes G.C. · Sathe P.A. · Kandalkar B.M.

Author affiliations

Department of Cytopathology, Seth G.S. Medical College and King Edward Memorial Hospital, Mumbai, India

Corresponding Author

Correspondence to: Dr. Sandeep Ojha

Department of Cytopathology

Seth G.S. Medical College and K.E.M. Hospital

Parel, Mumbai 400012 (India)

Tel. +91 99 3042 0581, E-Mail drsandy0582@gmail.com

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


Background: Infantile digital fibromatosis (IDF) or inclusion body fibromatosis is a benign proliferation of fibroblastic and myofibroblastic cells. Its most common site is the digits of young children and it is named for the intracytoplasmic inclusions that are detected in lesional cells. Case: A two and a half-year-old male child presented with a single flesh-colored nodule on the dorsal aspect of his right little toe since the sixth month of life. FNAC from the lesion showed characteristic cytomorphological features of IDF. Conclusion: IDF is a rare lesion occurring in children or infants. There are many case reports describing histopathological features of IDF. To our knowledge, the typical inclusion bodies as cytomorphological findings in IDF have not been described in the literature. This is a rare case diagnosed on cytology and confirmed on histopathology.

© 2011 S. Karger AG, Basel

Article / Publication Details

First-Page Preview
Abstract of Novel Insights from Clinical Practice

Received: May 25, 2011
Accepted: June 30, 2011
Published online: October 08, 2011

Number of Print Pages: 4
Number of Figures: 4
Number of Tables: 0

ISSN: 0001-5547 (Print)
eISSN: 1938-2650 (Online)

For additional information: http://www.karger.com/ACY

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.